Celtic House Asia Partners — 2025 Investments
1 investments dated 2025 · listed companies and verified rows first · show all
Wearlinq develops the eWave, a wireless, FDA-cleared 6-lead continuous ECG cardiac monitor with a patient smartphone app and the LiveLinq platform for clinicians to review ECG waveforms and reports.
Digital HealthHardwareMedical DevicesSan Francisco, US
Michael Torres(Executive Officer)inChris Daniel(Executive Officer)inYuxin Liu(Executive Officer, Director)Konrad Morzkowski(Executive Officer, Director)
BoardKrish W. Ramadurai(Director)inJoseph Knight(Director)
Co-investorsAIX VenturesAju IB Invesment CorporationAmino CapitalHealthtech Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.